X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Market Moves

Cold Chain Technologies Supports the Boston Marathon® Jimmy Fund Walk Insulated packaging leader is the official sponsor of Refueling Station #6 in Wellesley, Massachusetts

Yuvraj_pawp by Yuvraj_pawp
8th September 2014
in Market Moves

Cold Chain Technologies (CCT), a market leading global manufacturer of insulated packaging solutions is proud to announce its participation in the Boston Marathon® Jimmy Fund Walk presented by Hyundai on September 21, 2014 as the official sponsor of Refueling Station #6 in Wellesley, Massachusetts. As sponsor of Refueling Station #6, employee volunteers of Cold Chain Technologies will distribute food and beverages to thousands of walkers en route to the Copley Square finish line. In addition to sponsoring the refueling station, CCT has organized Team Cold Chain, a group of walkers comprised of employees that have joined together to raise funds.

“We are honored to partake in such a special community event for a very worthy cause. Cancer is a disease that directly or indirectly affects us all. Not only are we proud to be a refueling station sponsor, but we’ve also organized a team of inspired employees that will participate in the Boston Marathon Jimmy Fund Walk to contribute additional support to Dana-Farber Cancer Institute and the Jimmy Fund,” said Larry Gordon, president of Cold Chain Technologies.

 

More than 8,500 participants are expected to participate in the Boston Marathon Jimmy Fund Walk, to honor friends, family, co-workers, and patients facing all forms of cancer. Walkers will complete one of the four routes: 26.2 miles starting from Hopkinton; 13.1 miles starting in Wellesley; 5 miles from Boston College; and 3 miles from Dana-Farber Cancer Institute’s campus, which includes many patients and their families. All routes end at the Copley Square finish line in Boston. Walkers begin in Hopkinton between 5:30 and 7:30 a.m. (rolling start); at Wellesley High School between 8:30 and 10:30 a.m. (rolling start); at Boston College between 10 a.m. and 12 p.m. (rolling start); and at Dana-Farber at 1:30 p.m.

 

The Boston Marathon Jimmy Fund Walk is the only event other than the Boston Marathon® itself that is sanctioned by the Boston Athletic Association to use the historic route. Since 1989, the Boston Marathon Jimmy Fund Walk has contributed nearly $95 million to support pediatric and adult cancer research and patient care at the Dana-Farber.

 

About The Jimmy Fund

 

The Jimmy Fund (www.JimmyFund.org) solely supports Boston’s Dana-Farber Cancer Institute, raising funds for adult and pediatric cancer care and research to improve the chances of survival for cancer patients around the world. It is an official charity of the Boston Red Sox, as well as the official charity of the Massachusetts Chiefs of Police Association, the Pan-Mass Challenge, and the Variety Children’s Charity of New England. Since 1948, the generosity of millions of people has helped the Jimmy Fund save countless lives and reduce the burden of cancer for patients and families worldwide. Follow the Jimmy Fund on Facebook: www.facebook.com/thejimmyfund and on Twitter: @TheJimmyFund.

 

About Dana-Farber Cancer Institute

 

Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, is world-renowned for its leadership in adult and pediatric cancer treatment and research. Designated as a comprehensive cancer center by the National Cancer Institute (NCI), it is one of the largest recipients among independent hospitals of NCI and National Institutes of Health grant funding. For more information, go to www.dana-farber.org.

 

About Cold Chain Technologies

 

Cold Chain Technologies (CCT) is a trusted worldwide provider of compliant thermal packaging solutions for the distribution and transport of temperature sensitive products. CCT’s full line of KoolTemp® insulated containers and Koolit® refrigerant products, and KoolTemp® GTS qualified shipping solutions are manufactured and distributed globally. Headquartered in Holliston, Massachusetts, Cold Chain Technologies is an ISO 9001:2008 registered company with over 45 years of ensuring product safety for the pharmaceutical, life science and food service industries.

 

SOURCE Cold Chain Technologies

Tags: Massachusetts
Previous Post

Sigma Pharmaceuticals buys Discount Drug Stores for $26.7m

Next Post

Par Pharmaceutical Resumes Shipment of Generic Precedex® Injection

Related Posts

Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m
Market Moves

Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m

18th July 2022
Could The Long Deckline In Biotechnology M&A Be Ending
Featured

Could The Long Deckline In Biotechnology M&A Be Ending

16th July 2022
EMA Advises Recall of AbbVie, Biogen MS Drug
Market Moves

No Rush In Indian Generic Drug Firms To Launch COVID Products

16th July 2022
Market Moves

Gerresheimer raises revenue guidance for 2022 to double-digit growth after strong first quarter

8th April 2022
Regeneron, Intellia to develop CRISPR/Cas9-based treatments
Market Moves

Metagenomi Closes Oversubscribed $175M Series B Financing to Advance Therapeutic Pipeline and Expand Novel Gene Editing Platform

29th January 2022
Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe
Market Moves

Indian Pharma Industry To Grow By 9-11% In FY22- ICRA

7th January 2022
Next Post

Par Pharmaceutical Resumes Shipment of Generic Precedex® Injection

Latest News

FDA Approvals

NHS Acquires Potentially Lifesaving Breast Cancer Medication

9th November 2022
Clinical Trials

Transfusion of The First Patients Lab-Grown Blood Cells

9th November 2022
Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In